Several subsets of regulatory CD4+ T cells (CD4+ Tregs) have been described in peripheral
blood and tumor microenvironment of breast cancer (BC) patients and may play a role in the …

Abstract Background Persistent high-risk Human papillomavirus (HR-HPV) infections are the
main cause of cervical cancer. Cumulative evidence implicates regulatory T cells (Tregs) as …

AIM To detect human papilloma virus (HPV) presence and to characterize cellular immune
response in breast cancer patients. METHODS A total of 74 women were included, of which …

Oncogenic human papillomavirus (HPV)-infection is crucial for developing cervical cancer
and its precursor lesions [cervical intraepithelial neoplasia (CIN)]. Regulatory T cells (Tregs) …

Evidence from breast cancer patients suggests that increased T suppressor cells activity
may be associated with poor immune responses to tumor antigens and contribute to immune …

Background T regulatory cells (Tregs) are known to negatively control immune response.
The frequency of these cells was inversely correlated with clinical outcomes of breast …

A detailed analyses of HPV‐specific immunity was performed in a large group of patients
with HPV‐induced cervical cancer (CxCa) in relation to HLA‐types and prognostic factors …

Purpose Immune response plays an important role in cancer progression. In humans, the
study of the inflammatory infiltrate in malignancies, mainly T lymphocytes, has been a …

Background: The balance in the immune system between immune surveillance against non–
self-antigens and tolerance of self-antigens is known to be associated with the prognosis of …

The observed high percentage of CD25+/FOXP3+/CD127 (–/low) T cells within CD3+/CD4+
T cells in PR (–) breast cancer patients when compared to PR (+) breast cancer patients …